Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...

If you see your cardiologist and they throw out the term “heart failure,” your heart might figuratively skip a beat. The ...

If you are one of those who pop painkillers all too often, then you might be raising your risk of heart attack and heart ...

Explore the latest advancements in heart disease medications, including statins, beta-blockers, ACE inhibitors, and more, for improved heart health.

The classification of drugs have been around since 1964 after Sir James Black discovered how they can assist people with ...

A comprehensive new study supports evidence of the myriad health benefits of GLP-1 medications like Ozempic and Mounjaro — ...

Trials and Tribulations of Cell Therapy for Heart Failure, an Update on Ongoing Trials Dec. 2, 2024 — A critical review of cell-based and cell product-based therapies for the treatment of heart ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...